newsThe top 20 biopharma companies averaged a market capitalisation decline…
6 December 2022 | By Catherine Eckford (European Pharmaceutical Review)
The top 20 biopharma companies averaged a market capitalisation decline of $3.45 trillion in Q2 to $3.14 trillion in Q3 2022, says GlobalData.